Evaluating a New Marker for Risk Prediction Using the Test Tradeoff: An Update

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The International Journal of Biostatistics

• Publication date

  2012-03-22

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1515/1557-4679.1395PMID 22499728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies

  2011cited by this paper
• Prediction models: revolutionary in principle, but do they do more good than harm?

  2011cited by this paper
• Comparing costs associated with risk stratification rules for t-year survival.

  2011influential reference
• External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients.

  2010cited by this paper
• Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

  2010cited by this paper
• Simple and flexible classification of gene expression microarrays via Swirls and Ripples

  2010cited by this paper
• Evaluating diagnostic tests: The area under the ROC curve and the balance of errors

  2010cited by this paper
• Assessment of claims of improved prediction beyond the Framingham risk score.

  2009cited by this paper
• Evaluating health risk models

  2009cited by this paper
• Using relative utility curves to evaluate risk prediction

  2009influential reference
• Putting risk prediction in perspective: relative utility curves.

  2009influential reference
• Measures to Summarize and Compare the Predictive Capacity of Markers

  2009cited by this paper
• The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop

  2009cited by this paper
• Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study

  2008cited by this paper
• Bmc Medical Informatics and Decision Making Extensions to Decision Curve Analysis, a Novel Method for Evaluating Diagnostic Tests, Prediction Models and Molecular Markers

  2008cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Smooth semiparametric receiver operating characteristic curves for continuous diagnostic tests

  2007cited by this paper
• Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

  2007cited by this paper
• The Skill Plot: A Graphical Technique for Evaluating Continuous Diagnostic Tests

  2007cited by this paper
• Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

  2007cited by this paper
• Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.

  2007cited by this paper
• Decision Curve Analysis: A Novel Method for Evaluating Prediction Models

  2006influential reference
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• On criteria for evaluating models of absolute risk.

  2005cited by this paper
• Validation and updating of predictive logistic regression models: a study on sample size and shrinkage

  2004cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• Robust Classification for Imprecise Environments

  2000cited by this paper
• Assessing the Generalizability of Prognostic Information

  1999cited by this paper
• Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer

  1999cited by this paper
• Comparison of receiver operating characteristic curves on the basis of optimal operating points.

  1996cited by this paper
• Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

  1995cited by this paper
• Basic principles of ROC analysis.

  1978cited by this paper
• A primer for policy analysis

  1978cited by this paper
• Signal detection theory and ROC analysis

  1975cited by this paper
• Therapeutic decision making: a cost-benefit analysis.

  1975cited by this paper
• Two further applications of a model for binary regression

  1958cited by this paper
• The numerical measure of the success of predictions.

  1884cited by this paper

• Comparing diagnostic tests and biomarkers based on benefit-risk under tree orderings of disease classes.

  2025cites this paper
• Calibrating machine learning approaches for probability estimation: A short expansion

  2024cites this paper
• A new integrated discrimination improvement index via odds

  2024cites this paper
• Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?

  2024cites this paper
• Net benefit of diagnostic tests for multistate diseases: an indicator variables approach

  2023influential citation
• Evaluating Risk Prediction with Data Collection Costs: Novel Estimation of Test Tradeoff Curves

  2023cites this paper
• Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review

  2022cites this paper
• Clinical utility gains from incorporating comorbidity and geographic location information into risk estimation equations for atherosclerotic cardiovascular disease

  2022cites this paper
• Recalibration Methods for Improved Clinical Utility of Risk Scores

  2021influential citation
• Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population

  2021cites this paper
• Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening

  2020cites this paper
• Metrics for Evaluating Polygenic Risk Scores.

  2020cites this paper
• Assessing the clinical utility of genetic profiling in fracture risk prediction: a decision curve analysis

  2020cites this paper
• Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review.

  2019cites this paper
• Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.

  2019cites this paper
• Decision Curves and Relative Utility Curves

  2019cites this paper
• Design and Analysis Considerations for a Sequentially Randomized HIV Prevention Trial

  2019cites this paper
• Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

  2018cites this paper
• Beyond discrimination: A comparison of calibration methods and clinical usefulness of predictive models of readmission risk

  2017cites this paper
• Distribution-Free Approaches to Assessing the Potential Clinical Impact of Biomarkers

  2017cites this paper
• Simple Decision-Analytic Functions of the AUC for Ruling Out a Risk Prediction Model and an Added Predictor

  2017cites this paper
• The summary test tradeoff: a new measure of the value of an additional risk prediction marker

  2017cites this paper
• Comparing diagnostic tests on benefit-risk

  2016cites this paper
• A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study.

  2015cites this paper
• Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.

  2015cites this paper
• The Net Reclassification Index (NRI): A Misleading Measure of Prediction Improvement Even with Independent Test Data Sets

  2015cites this paper
• Calibration of Risk Prediction Models

  2015cites this paper
• Vardeman, S. B. and Morris, M. D. (2013), “Majority Voting by Independent Classifiers can Increase Error Rates,” The American Statistician, 67, 94-96: Comment by Baker, Xu, Hu, and Huang and Reply

  2014cites this paper
• How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through

  2014cites this paper
• Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.

  2014cites this paper
• The Net Reclassification Index (NRI): A Misleading Measure of Prediction Improvement Even with Independent Test Data Sets

  2014cites this paper
• Combined Benefit of Prediction and Treatment: A Criterion for Evaluating Clinical Prediction Models

  2014cites this paper
• Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives

  2014cites this paper
• Letters to the Editor

  2013cites this paper
• The contribution of risk prediction models to early detection of lung cancer

  2013cites this paper
• Evaluation of Markers and Risk Prediction Models

  2013cites this paper
• Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer

  2012cites this paper
• Evaluating a new marker for risk prediction: decision analysis to the rescue.

  2012cites this paper
• Supplementary Issue: Classification, Predictive Modelling, and Statistical Analysis of Cancer Data (a) Introduction – Assessing Prediction Models to Support Clinical Decisions

  year unknowncites this paper